Skip to main content

Table 2 Predictors of SVR12 by univariate and multivariate logistic regression analysis

From: Effectiveness of direct-acting antiviral therapy for hepatitis C in difficult-to-treat patients in a safety-net health system: a retrospective cohort study

Variable Univariate analysis (OR, 95% CI) Multivariate analysis (OR, 95% CI) Absolute SVR12 rates (%)
Female sex (N = 224) 1.73 (0.95–3.19) 1.64 (0.89–3.02) 92% (vs. male sex 88%)
Cirrhosis status    
 No cirrhosis (N = 250) Reference Reference 92.8%
 Compensated cirrhosis (N = 206) 0.56 (0.30–1.06) 0.60 (0.32–1.14) 87.9%
 Decompensated cirrhosis (N = 56) 0.36 (0.15–0.82) 0.37 (0.16–0.85) 82.1%
  1. Statistical significance defined as P < 0.10 for univariate and P < 0.05 for multivariate analysis
  2. SVR12 sustained virologic response at 12 weeks after treatment end, OR odds ratio, CI confidence interval